Henner Zirpel
Luebeck, SH, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Evaluating Risankizumab's Long-Term Effects in Psoriasis Using Optical Coherence Tomography.
Journal: Dermatology and therapy
Published: October 01, 2025
Dupilumab treatment is not associated with changes in lymphoma risk in atopic dermatitis and other type 2 inflammatory diseases: data from a large-scale retrospective cohort study.
Journal: Frontiers in medicine
Published: September 10, 2025
COVID-19 Infection vs Vaccination and the Risk of New-onset Psoriasis.
Journal: Acta dermato-venereologica
Published: June 24, 2025
Transition From Psoriasis to Psoriatic Arthritis is Characterized by Distinct Alterations in Peripheral Blood Tc17, Th17, and CD4+ Effector Memory Cells.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: March 09, 2025
Dupilumab shows no elevated risk for maternal adverse pregnancy outcomes: A propensity-matched cohort study.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: December 15, 2024
Increased risk of psychiatric disease in patients with prurigo nodularis.
Journal: The British journal of dermatology
Published: November 16, 2024
Comparison of safety profile in patients with atopic dermatitis treated with dupilumab or conventional systemic treatment: real world data from the US network.
Journal: The Journal of dermatological treatment
Published: November 03, 2024
Large-scale analysis highlights obesity as a risk factor for chronic, non-communicable inflammatory diseases.
Journal: Frontiers in endocrinology
Published: October 30, 2024
A comprehensive review of methodologies and application to use the real-world data and analytics platform TriNetX.
Journal: Frontiers in pharmacology
Published: October 24, 2024
Glucagon-like peptide-1 receptor agonists and reduced mortality, cardiovascular and psychiatric risks in patients with psoriasis: a large-scale cohort study.
Journal: The British journal of dermatology
Published: September 02, 2024
COVID-19 infection is associated with an elevated risk for autoimmune blistering diseases while COVID-19 vaccination decreases the risk: A large-scale population-based cohort study of 112 million individuals.
Journal: Journal of the American Academy of Dermatology
Published: August 06, 2024
Risk of developing sleep disorders and psychologic comorbidity in children with inflammatory skin diseases-A population-based study.
Journal: Journal of the American Academy of Dermatology
Published: April 29, 2024
Last Updated: 09/26/2026